GSE171837 0 V 3 BORTEZOMIB MOUSE UP (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE171837 0 V 3 BORTEZOMIB MOUSE UP.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE171837 0 V 3 BORTEZOMIB MOUSE UP.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE171837 0 V 3 BORTEZOMIB MOUSE UP.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE171837 0 V 3 BORTEZOMIB MOUSE UP.

Results found

Linked to

 

Label

Description

 

Gene

ASNSD1 upstream open reading frame

Gene

cytochrome c oxidase copper chaperone COX17

Gene

SUMO specific peptidase 1

Gene

glycine cleavage system protein H

Gene

B cell receptor associated protein 29

Gene

exosome component 9

Gene

tRNA splicing endonuclease subunit 15

Gene

zinc finger CW-type and PWWP domain containing 1

Gene

SRY-box transcription factor 6

Gene

transmembrane protein 126A

  • Gene

    ASNSD1 upstream open reading frame


  • Gene

    cytochrome c oxidase copper chaperone COX17


  • Gene

    SUMO specific peptidase 1


  • Gene

    glycine cleavage system protein H


  • Gene

    B cell receptor associated protein 29


  • Gene

    exosome component 9


  • Gene

    tRNA splicing endonuclease subunit 15


  • Gene

    zinc finger CW-type and PWWP domain containing 1


  • Gene

    SRY-box transcription factor 6


  • Gene

    transmembrane protein 126A

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.